Morning Buzz: NetEase (NTES), Angie’s List (ANGI), Apparatus Regenerative (HART), Digital Ally (DGLY)

NetEase, Inc. (NTES) shares are up $9.44 to $159.51 in pre-market trading Thursday after the company reported better-than-expected third-quarter earnings.

The online game developer posted EPS of $2.44 on revenues of $1.05 billion, up 114.1% from a year ago, and 19% higher than consensus estimates. Analysts were expecting EPS of $2.12 on revenues of $876.46 million.

Shares of Angie’s List, Inc. (ANGI) have risen 11.24% in pre-market trading Thursday following this morning’s announcement of a deal to be acquired by IAC/InterActiveCorp (IACI), the owner of websites including and for about $512 million.

“The combination of the Angie’s List brand, highly-trafficked website and its network of paying service professionals with our HomeAdvisor business, the category leader which has seen eight consecutive quarters of accelerating growth in its core U.S. business, would cement our position as the premier home services platform,” said in a statement Joey Levin, CEO of IAC/InterActive

New York City-based IAC has offered $8.75 for each share of Angie’s List stock. The offer represents a 10 percent premium to the $7.92 closing price of ANGI on Wednesday.

Shares of Harvard Apparatus Regenerative Technology, Inc. (HART) are skyrocketing by 130.81% to $1.38 at the start of trading on Thursday morning, after the company developing bioengineered implants for life-threatening conditions reported significant results from animal research on its 2nd Generation bioengineered implant platform.

Shares of Digital Ally Inc. (DGLY) continue to fall on Thursday, down $1.92, or 25.57%, at $5.59 following the co.’s disappointing earnings/guidance.

Digital Ally Inc. reported third-quarter EPS of ($0.45), compared to the consensus estimate of ($0.09). Revenues increased 9.2% from last year to $5.1 million. Analysts expected revenues of $6.76 million.

For FY15, DGLY issued revenue projection of less than $25 million, compared to the consensus revenue estimate of $25.10 million.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.